Derm-Biome Pharmaceuticals, Inc. is a startup biopharmaceutical company founded in 2018 through its purchase of proprietary birch bark natural compound derivatives. Almost $6M dollars has been invested into advancing our suite of compounds, resulting in promising results showing that they have potent anti-inflammatory effects in diseases such as atopic dermatitis, they have anti-microbial activity to potentially balance the sk...
Derm-Biome Pharmaceuticals, Inc. is a startup biopharmaceutical company founded in 2018 through its purchase of proprietary birch bark natural compound derivatives. Almost $6M dollars has been invested into advancing our suite of compounds, resulting in promising results showing that they have potent anti-inflammatory effects in diseases such as atopic dermatitis, they have anti-microbial activity to potentially balance the skin microbiome, they improve skin appearance (potentially through enhanced skin turnover), and they are highly selective for killing tumor cells versus normal cells derived from patients with skin cancer.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.